Protara Therapeutics Inc.
06/29/2026 | Press release | Distributed by Public on 06/29/2026 15:03
Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Protara Therapeutics, Inc. (the "Company") announced that Leonardo Viana Nicacio, M.D., Chief Medical Officer of the Company, resigned from the Company to explore other opportunities, effective as of June 26, 2026. Dr. Nicacio's duties will be subsumed by Carla Beckham, M.D., the Company's Lead Medical Director and Head of Clinical Development, and will continue under the oversight of Jacqueline Zummo, Ph.D., the Company's Chief Research & Development Officer.
Protara Therapeutics Inc. published this content on June 29, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 29, 2026 at 21:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]